Literature DB >> 24342922

Genetic therapies: Correcting genetic defects with CRISPR-Cas9.

Isabel Lokody.   

Abstract

Entities:  

Year:  2013        PMID： 24342922     DOI： 10.1038/nrg3656

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN： 1471-0056            Impact factor:   53.242


× No keyword cloud information.
  2 in total

1.  Correction of a genetic disease in mouse via use of CRISPR-Cas9.

Authors:  Yuxuan Wu; Dan Liang; Yinghua Wang; Meizhu Bai; Wei Tang; Shiming Bao; Zhiqiang Yan; Dangsheng Li; Jinsong Li
Journal:  Cell Stem Cell       Date:  2013-12-05       Impact factor: 24.633

2.  Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.

Authors:  Gerald Schwank; Bon-Kyoung Koo; Valentina Sasselli; Johanna F Dekkers; Inha Heo; Turan Demircan; Nobuo Sasaki; Sander Boymans; Edwin Cuppen; Cornelis K van der Ent; Edward E S Nieuwenhuis; Jeffrey M Beekman; Hans Clevers
Journal:  Cell Stem Cell       Date:  2013-12-05       Impact factor: 24.633
  2 in total
  4 in total

1.  Decoding the complex genetic causes of heart diseases using systems biology.

Authors:  Djordje Djordjevic; Vinita Deshpande; Tomasz Szczesnik; Andrian Yang; David T Humphreys; Eleni Giannoulatou; Joshua W K Ho
Journal:  Biophys Rev       Date:  2014-12-10

Review 2.  Customizing the genome as therapy for the β-hemoglobinopathies.

Authors:  Matthew C Canver; Stuart H Orkin
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

Review 3.  International regulatory landscape and integration of corrective genome editing into in vitro fertilization.

Authors:  Motoko Araki; Tetsuya Ishii
Journal:  Reprod Biol Endocrinol       Date:  2014-11-24       Impact factor: 5.211

4.  Nanoparticle elasticity directs tumor uptake.

Authors:  Peng Guo; Daxing Liu; Kriti Subramanyam; Biran Wang; Jiang Yang; Jing Huang; Debra T Auguste; Marsha A Moses
Journal:  Nat Commun       Date:  2018-01-09       Impact factor: 14.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.